Strides labs(Bangalore) which is into manufacturing of sterile injectables and oral dosage formulations with global presence in Latin America, Africa, US, Southeast Asia and also has several manufacturing facilities overseas is interested in selling stakes of its branded-generics pharmaceutical company.Potential investors may think of investing in the specialty pharma unit, which is focused on manufacturing of sterile injectables as one report states that the global injectable market is estimated to grow from USD 150 billion in year 2008 to USD 245 billion by 2012.
No comments:
Post a Comment